| Business Summary | | ESCAgenetics
Corporation
was
organized
to
develop
and
commercialize
high-value,
plant
derived
products
for
the
agricultural
and
pharmaceutical
markets.
The
Company
was
dormant
during
fiscal
2000.
The
Company
does
not
plan
to
continue
the
business
activities
that
it
conducted
prior
to
its
reorganization.
It
plans
to
pursue
a
business
combination
or
other
strategic
transaction. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | ESCAgenetics
Corp.
was
organized
to
develop
and
commercialize
high-value,
plant
derived
products
for
the
agricultural
and
pharmaceutical
markets.
In
January
1995,
the
Company
scaled
back
its
business
activities
and
became
largely
a
dormant
business.
For
the
nine
months
ended
6/30/01,
the
Company
reports
no
revenues.
Net
loss
decreased
28%
to
$29
thousand.
Revenues
reflect
the
absence
of
any
revenue-generating
activities.
Lower
loss
reflects
lower
operating
expenses. | More
from
Market Guide: Significant
Developments |
| Officers | |
| Position | Michelle Kline, 42 | Pres,
Treasurer, Sec., Director |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|